Seeking Alpha

Jessica King Holden

 
View as an RSS Feed
View Jessica King Holden's Comments BY TICKER:
Latest  |  Highest rated
  • Interferon's Role In Flu Control Shouldn't Be Underestimated [View article]
    Edward,
    You bring up good points. My slant on this concept is from the science side of things which does not always govern the market or public opinion. Financially, SVA may be undervalued considering its cash position. NVAX is likely just one pandemic scare away from a jump, long term the jury is out.

    HEB is a speculative stock in an area that is exciting for potential benefits, even moreso than vaccination. In the event of a huge spreading epidemic, low dose oral interferon would be one of the only if not the only plausible way to treat a mass of people in an area already affected. I would simply expect, scientifically speaking, that interferon for the treatment of flu and like viruses will increase in coming years meaning more partnerships for microcap biotechs and big pharma gaining more interest.
    Jan 12 07:27 PM | Likes Like |Link to Comment
  • Emergent BioSciences And Regeneron Gain Attention Going Into 2012 [View article]
    It will be interesting to see if REGN breaks its 52 week high in the coming days.
    Jan 10 02:34 PM | Likes Like |Link to Comment
  • Regeneron Finally Makes It To The Market [View article]
    Agreed! Have to say it's amazing, its longevity. Now with a viable drug on the market, who knows!
    Jan 10 11:26 AM | Likes Like |Link to Comment
COMMENTS STATS
18 Comments
3 Likes